Literature DB >> 1885730

Simplified microtiter cell culture method for rapid immunotyping of Chlamydia trachomatis.

R J Suchland1, W E Stamm.   

Abstract

Serotyping of Chlamydia trachomatis strains usually requires three to six serial passages in shell vials to attain sufficient antigen for typing procedures. To circumvent this problem, we developed a rapid low-passage method for serotyping of C. trachomatis clinical isolates. Isolates with an inclusion count of greater than or equal to 500 per well in primary isolation were inoculated directly onto cell culture monolayers in microtiter plates for typing. Primary isolates with a lower initial inclusion count were passed one to two times in shell vials until there were greater than or equal to 20 inclusions per well and were then inoculated onto plates for typing. Inclusions were grown to maturity and reacted with a panel of 17 C. trachomatis-specific monoclonal antibodies in pools. Wells were then reacted with a fluorescein isothiocyanate conjugate and read by FA microscopy, and the reaction patterns were compared with prototype strain reaction patterns to determine the serotype. By the microtiter method, we successfully typed 1,711 consecutive C. trachomatis isolates; 1,215 isolates (71%) were typed with no or with one passage. The first 209 isolates typed by the microtiter method were also typed by the dot-enzyme-linked immunosorbent assay serotyping method; 100% agreement was demonstrated among strains that were typeable by both methods. We conclude that the microtiter method is extremely useful for accurate serotyping of large numbers of isolates and requires greatly reduced technician time.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1885730      PMCID: PMC270111          DOI: 10.1128/jcm.29.7.1333-1338.1991

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  16 in total

1.  Nucleotide and deduced amino acid sequences for the four variable domains of the major outer membrane proteins of the 15 Chlamydia trachomatis serovars.

Authors:  Y Yuan; Y X Zhang; N G Watkins; H D Caldwell
Journal:  Infect Immun       Date:  1989-04       Impact factor: 3.441

2.  Serovar distribution of urogenital Chlamydia trachomatis strains in The Netherlands.

Authors:  J H Wagenvoort; R J Suchland; W E Stamm
Journal:  Genitourin Med       Date:  1988-06

3.  Purification on renografin density gradients of Chlamydia trachomatis grown in the yolk sac of eggs.

Authors:  L Howard; N S Orenstein; N W King
Journal:  Appl Microbiol       Date:  1974-01

4.  Immunotyping of Chlamydia trachomatis with monoclonal antibodies.

Authors:  S P Wang; C C Kuo; R C Barnes; R S Stephens; J T Grayston
Journal:  J Infect Dis       Date:  1985-10       Impact factor: 5.226

5.  Derivation of specific antibody-producing tissue culture and tumor lines by cell fusion.

Authors:  G Köhler; C Milstein
Journal:  Eur J Immunol       Date:  1976-07       Impact factor: 5.532

6.  Rapid immunotyping of Chlamydia trachomatis with monoclonal antibodies in a solid-phase enzyme immunoassay.

Authors:  R C Barnes; S P Wang; C C Kuo; W E Stamm
Journal:  J Clin Microbiol       Date:  1985-10       Impact factor: 5.948

7.  Protective monoclonal antibodies recognize epitopes located on the major outer membrane protein of Chlamydia trachomatis.

Authors:  Y X Zhang; S Stewart; T Joseph; H R Taylor; H D Caldwell
Journal:  J Immunol       Date:  1987-01-15       Impact factor: 5.422

8.  Detection of multiple serovars of Chlamydia trachomatis in genital infections.

Authors:  R C Barnes; R J Suchland; S P Wang; C C Kuo; W E Stamm
Journal:  J Infect Dis       Date:  1985-11       Impact factor: 5.226

9.  Correlation of infecting serovar and local inflammation in genital chlamydial infections.

Authors:  B E Batteiger; W Lennington; W J Newhall; B P Katz; H T Morrison; R B Jones
Journal:  J Infect Dis       Date:  1989-08       Impact factor: 5.226

10.  A simplified method for immunological typing of trachoma-inclusion conjunctivitis-lymphogranuloma venereum organisms.

Authors:  S P Wang; C C Kuo; J T Grayston
Journal:  Infect Immun       Date:  1973-03       Impact factor: 3.441

View more
  31 in total

1.  Susceptibility of Chlamydia trachomatis to excipients commonly used in topical microbicide formulations.

Authors:  M F Lampe; L C Rohan; M C Skinner; W E Stamm
Journal:  Antimicrob Agents Chemother       Date:  2004-08       Impact factor: 5.191

2.  Development of secondary inclusions in cells infected by Chlamydia trachomatis.

Authors:  Robert J Suchland; Daniel D Rockey; Sara K Weeks; Damir T Alzhanov; Walter E Stamm
Journal:  Infect Immun       Date:  2005-07       Impact factor: 3.441

3.  Human Fallopian Tube Epithelial Cell Culture Model To Study Host Responses to Chlamydia trachomatis Infection.

Authors:  Scott H Randell; Toni Darville; Uma M Nagarajan; Bryan E McQueen; Amy Kiatthanapaiboon; M Leslie Fulcher; Mariam Lam; Kate Patton; Emily Powell; Avinash Kollipara; Victoria Madden; Robert J Suchland; Priscilla Wyrick; Catherine M O'Connell; Boris Reidel; Mehmet Kesimer
Journal:  Infect Immun       Date:  2020-08-19       Impact factor: 3.441

4.  Chlamydia trachomatis major outer membrane protein variants escape neutralization by both monoclonal antibodies and human immune sera.

Authors:  M F Lampe; K G Wong; L M Kuehl; W E Stamm
Journal:  Infect Immun       Date:  1997-01       Impact factor: 3.441

Review 5.  Emancipating Chlamydia: Advances in the Genetic Manipulation of a Recalcitrant Intracellular Pathogen.

Authors:  Robert J Bastidas; Raphael H Valdivia
Journal:  Microbiol Mol Biol Rev       Date:  2016-03-30       Impact factor: 11.056

6.  Evaluation of WLBU2 peptide and 3-O-octyl-sn-glycerol lipid as active ingredients for a topical microbicide formulation targeting Chlamydia trachomatis.

Authors:  M C Skinner; A O Kiselev; C E Isaacs; T A Mietzner; R C Montelaro; M F Lampe
Journal:  Antimicrob Agents Chemother       Date:  2009-12-14       Impact factor: 5.191

7.  Identification of concomitant infection with Chlamydia trachomatis IncA-negative mutant and wild-type strains by genomic, transcriptional, and biological characterizations.

Authors:  Robert J Suchland; Brendan M Jeffrey; Minsheng Xia; Ajay Bhatia; Hencelyn G Chu; Daniel D Rockey; Walter E Stamm
Journal:  Infect Immun       Date:  2008-10-13       Impact factor: 3.441

8.  Chlamydia trachomatis laboratory strains versus recent clinical isolates: implications for routine microbicide testing.

Authors:  M C Skinner; W E Stamm; M L Lampe
Journal:  Antimicrob Agents Chemother       Date:  2009-02-02       Impact factor: 5.191

9.  Direct detection and genotyping of Chlamydia trachomatis in cervical scrapes by using polymerase chain reaction and restriction fragment length polymorphism analysis.

Authors:  J Lan; J M Walboomers; R Roosendaal; G J van Doornum; D M MacLaren; C J Meijer; A J van den Brule
Journal:  J Clin Microbiol       Date:  1993-05       Impact factor: 5.948

10.  Analysis of pmpD expression and PmpD post-translational processing during the life cycle of Chlamydia trachomatis serovars A, D, and L2.

Authors:  Andrey O Kiselev; Megan C Skinner; Mary F Lampe
Journal:  PLoS One       Date:  2009-04-15       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.